Zevra Therapeutics Stock Quote ZVRA - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

8.72

Bid

8.44

Ask

8.89

Volume

2,543,375

8.343 Day's Range 8.83

4.20 52 Week Range 9.76

Market Cap

465.438M

Previous Close

8.54

Open

8.43

Last Trade

100

8.72

(formt)

Last Trade Time

Financial Volume

$ 21,783,831

VWAP

8.5649

Average Volume (3m)

651,855

Shares Outstanding

53,375,932

Dividend Yield

PE Ratio

-9.84

Earnings Per Share (EPS)

-0.86

Revenue

27.46M

Net Profit

-46.05M

Zevra Therapeutics, Inc. is a rare disease therapeutics company. The Company is engaged in creating therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical-stage pipeline and ... Zevra Therapeutics, Inc. is a rare disease therapeutics company. The Company is engaged in creating therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical-stage pipeline and commercial stage assets. It employs its LAT platform technology to create a portfolio of approved products. Its product candidates include Arimoclomol, KP1077IH, KP1077N and AZSTARYS. Arimoclomol is an orally delivered, investigational product candidate being developed for Niemann-Pick disease type C (NPC). KP1077 is the Company's lead clinical development product candidate, which is being developed as a treatment for idiopathic hypersomnia (IH) and narcolepsy. KP1077 is comprised solely of serdexmethylphenidate (SDX), the Company's prodrug of d-methylphenidate (d-MPH). AZSTARYS is a prodrug for the treatment of ADHD in patients aged six years or older. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kempharm.com

Headquarters

Wilmington, Delaware, USA

Founded

Zevra Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ZVRA. The last closing price for Zevra Therapeutics was $8.54. Over the last year, Zevra Therapeutics shares have traded in a share price range of $ 4.20 to $ 9.76.

Zevra Therapeutics currently has 53,375,932 shares outstanding. The market capitalization of Zevra Therapeutics is $455.83 million. Zevra Therapeutics has a price to earnings ratio (PE ratio) of -9.84.

Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024

CELEBRATION, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on addressing unmet needs for the...

Form 8-K - Current report

Zevra Therapeutics Announces Organizational Changes

CELEBRATION, Fla., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on addressing unmet needs for the...

Zevra Therapeutics to Participate at Upcoming Investor Conferences

CELEBRATION, Fla., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on addressing unmet needs for the...

Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C

MIPLYFFA, the first FDA-approved treatment for Niemann-Pick disease type C, is available at Zevra’s specialty pharmacy for dispense AmplifyAssist™, Zevra’s comprehensive patient support program...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.37	4.43113772455	8.35	8.79	8.17	476252	8.44287216	CS
4	-0.495	-5.37167661422	9.215	9.76	8.17	438215	9.00846679	CS
12	1.41	19.2886456908	7.31	9.76	6.61	651855	8.36894837	CS
26	4.27	95.9550561798	4.45	9.76	4.2	814207	7.53925091	CS
52	3.82	77.9591836735	4.9	9.76	4.2	533599	7.10482047	CS
156	3.07	54.3362831858	5.65	9.76	3.89	394468	6.59621274	CS
260	3.07	54.3362831858	5.65	9.76	3.89	394468	6.59621274	CS

ZVRA - Frequently Asked Questions (FAQ)

What is the current Zevra Therapeutics share price?

The current share price of Zevra Therapeutics is $ 8.72

How many Zevra Therapeutics shares are in issue?

Zevra Therapeutics has 53,375,932 shares in issue

What is the market cap of Zevra Therapeutics?

The market capitalisation of Zevra Therapeutics is USD 455.83M

What is the 1 year trading range for Zevra Therapeutics share price?

Zevra Therapeutics has traded in the range of $ 4.20 to $ 9.76 during the past year

What is the PE ratio of Zevra Therapeutics?

The price to earnings ratio of Zevra Therapeutics is -9.84

What is the cash to sales ratio of Zevra Therapeutics?

The cash to sales ratio of Zevra Therapeutics is 16.5

What is the reporting currency for Zevra Therapeutics?

Zevra Therapeutics reports financial results in USD

What is the latest annual turnover for Zevra Therapeutics?

The latest annual turnover of Zevra Therapeutics is USD 27.46M

What is the latest annual profit for Zevra Therapeutics?

The latest annual profit of Zevra Therapeutics is USD -46.05M

What is the registered address of Zevra Therapeutics?

The registered address for Zevra Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Zevra Therapeutics website address?

The website address for Zevra Therapeutics is www.kempharm.com

Which industry sector does Zevra Therapeutics operate in?

Zevra Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MYSZMy Size Inc	$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	$ 0.24 (65.06%)	354.32M
APTOAptose Biosciences Inc	$ 0.28 (64.51%)	305.1M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.606999 (6.49%)	292.16M
NVDANVIDIA Corporation	$ 134.70 (3.08%)	287.21M
PLTRPalantir Technologies Inc	$ 80.55 (8.54%)	277.63M